| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 247 | 229 | +7.9% |
| EBITDA | 11.8 | 11.4 | +3.9% |
| EBITDA margin | 4.8% | 5.0% | −0.2 pts |
| Profit before tax | 11.7 | 11.9 | −1.2% |
| Net profit | 8.9 | 9.5 | −6.0% |
| EPS | ₹1.78 | ₹1.89 | −5.8% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 |
|---|
| 343 | — | — | — | — | |
| 49.3 | 49.3 | 13.8 | 9.3 | 19.0 | |
| 7.6 | 7.6 | 2.8 | 10.0 | — | |
| 301 | — | — | — | — | |
| 940 | 922 | 734 | — | — | |
| — | +25.5% | — | — | — | |
| 43.9 | 43.4 | 48.0 | — | — | |
| 4.7% | 4.7% | 6.5% | — | — | |
| 38.0 | 37.7 | 42.6 | — | — | |
| 33.3 | 33.9 | 37.0 | — | — | |
| 3.5% | 3.7% | 5.0% | — | — | |
| ₹6.65 | ₹6.77 | ₹7.38 | — | — | |
| — | −8.4% | — | — | — | |
| — | 64.3 | 32.0 | 49.8 | 19.9 | |
| — | −5.6 | −4.6 | — | — | |
| 58.7 | 58.7 | 27.3 | 49.8 | 19.9 | |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 342.7 | |
| - Cash, Equiv & ST Investments | 19.0 | 9.3 | 13.8 | 49.3 | 49.3 | |
| + Total Debt | — | 10.0 | 2.8 | 7.6 | 7.6 | |
| Enterprise Value | — | — | — | — | 300.9 | |
| Revenue | — | — | 734.3 | 921.5 | 939.6 | |
| Growth %, YoY | — | — | — | +25.5 | — | |
| EBITDA | — | — | 48.0 | 43.4 | 43.9 | |
| Margin % | — | — | 6.54 | 4.71 | 4.67 | |
| EBIT | — | — | 42.6 | 37.7 | 38.0 | |
| Net Income | — | — | 37.0 | 33.9 | 33.3 | |
| Margin % | — | — | 5.04 | 3.68 | 3.55 | |
| EPS, Adj (current shares) | — | — | 7.38 | 6.77 | 6.65 | |
| Growth %, YoY | — | — | — | -8.4 | — | |
| Cash from Operations | 19.9 | 49.8 | 32.0 | 64.3 | — | |
| Capital Expenditures | — | — | -4.6 | -5.6 | — | |
| Free Cash Flow | 19.9 | 49.8 | 27.3 | 58.7 | 58.7 | |
Prices at the 30 October 2026 close · figures from the company's filings with NSE
Kriti Nutrients (NSE: KRITINUT) had a market capitalisation of ₹324 crore at the 30 October 2026 close (₹64.62 a share), a PE ratio of 9.7 on the last four quarters' profit and a price-to-book ratio of 1.41. In FY26 its consolidated net profit was ₹33.9 crore on revenue of ₹922 crore; in Q1 FY27 (April–June 2026) it was ₹8.9 crore, down 6.0% year on year. Its debt-to-equity ratio was 0.03 on 31 March 2026. Promoters held 66.68% of the shares on 30 September 2026.
Kriti Nutrients' PE ratio is 9.7 at the 30 October 2026 close (₹64.62 a share): a market capitalisation of ₹324 crore divided by consolidated net profit of ₹33.3 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹33.9 crore) it is 9.6.
Kriti Nutrients' debt-to-equity ratio was 0.03 on 31 March 2026: borrowings of ₹7.6 crore against total equity of ₹229 crore. A year earlier, on 31 March 2025, it was 0.01.
Kriti Nutrients' net worth — shareholders' equity in its consolidated balance sheet — was ₹229 crore on 31 March 2026, up 8.1% from ₹212 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹324 crore at the 30 October 2026 close.
Kriti Nutrients' price-to-book (PB) ratio is 1.41 at the 30 October 2026 close: a market capitalisation of ₹324 crore divided by shareholders' equity (book value) of ₹229 crore on 31 March 2026. That is a book value of ₹45.73 per share against a share price of ₹64.62.
In FY26, Kriti Nutrients' return on equity (ROE) was 15.4% and its return on capital employed (ROCE) was 16.6%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities).
Kriti Nutrients' book value per share was ₹45.73 on 31 March 2026: shareholders' equity of ₹229 crore divided by the 5.01 crore shares in issue, up 8.1% from ₹42.28 a year earlier. The share price at the 30 October 2026 close was ₹64.62.
Kriti Nutrients' market capitalisation was ₹324 crore at the 30 October 2026 close: 5.01 crore shares at ₹64.62 each.
No. Kriti Nutrients had borrowings of ₹7.6 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.03. Its cash and current investments were ₹62.2 crore, so it held net cash of ₹54.7 crore.
Kriti Nutrients' basic earnings per share (EPS) were ₹6.77 in FY26, against ₹7.38 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹6.66.
Kriti Nutrients' dividend yield is 4.64% at the 30 October 2026 close: dividends of ₹3 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹64.62. They were ₹3 on 13 November 2025 (special).
In FY26, Kriti Nutrients generated ₹64.3 crore of cash from operations and spent ₹5.6 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹58.7 crore. In FY25 it was ₹27.3 crore.
In FY26 (April 2025–March 2026), Kriti Nutrients' consolidated net profit was ₹33.9 crore, down 8.4% from ₹37 crore in FY25, on revenue from operations of ₹922 crore (up 25.5%).
Promoters held 66.68% of Kriti Nutrients on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
On 30 September 2026, Kriti Nutrients' shares were held by promoters 66.68%, domestic institutions (DII) 0.03% and retail and other non-institutional investors 33.29%. Over the year, DII holding was up 0.03 percentage points from 0.00%.
Kriti Nutrients will announce its Q2 FY27 results (July–September 2026) on Thursday, 5 November 2026, the date of the board meeting it has notified to the exchanges.
Kriti Nutrients' latest results are for Q1 FY27 (April–June 2026), filed on 11 August 2026: consolidated net profit ₹8.9 crore, down 6.0% from ₹9.5 crore in Q1 FY26; revenue from operations ₹247 crore, up 7.9% year on year.
On FY26 consolidated figures, against Gokul Refoils and Solvent, Halder Venture and M K Proteins: Kriti Nutrients' operating margin of 4.1% is the highest of the four (Gokul Refoils and Solvent 0.6%, Halder Venture 3.4%, M K Proteins 2.9%; peer average 2.3%); its return on equity of 15.4% is the second highest of the four (Gokul Refoils and Solvent 5.2%, Halder Venture 16.1%, M K Proteins 9.4%; peer average 10.2%).
At the 30 October 2026 closing prices, on FY26 net profit, Kriti Nutrients' PE ratio is 9.6, the lowest of the four: Gokul Refoils and Solvent 18.4, Halder Venture 10.9 and M K Proteins 20.3, a peer average of 16.5. Each is the company's market capitalisation at that price divided by its FY26 net profit.
In FY26, Kriti Nutrients earned net profit of ₹33.9 crore on revenue of ₹922 crore, against ₹18.5 crore on ₹4,120 crore for Gokul Refoils and Solvent. Kriti Nutrients' operating margin was 4.1% (Gokul Refoils and Solvent 0.6%) and its return on equity 15.4% (Gokul Refoils and Solvent 5.2%). At the 30 October 2026 close, Kriti Nutrients' market capitalisation was ₹324 crore against ₹339 crore for Gokul Refoils and Solvent, and its PE ratio on FY26 profit 9.6 against 18.4.
From Kriti Nutrients' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.